FIELD: ophthalmology. SUBSTANCE: invention consists in that, in addition to antiviral preparations, 0.5-% etaden solution is introduced into conjunctival cavity. EFFECT: speeded up epithelization of cornea and reduced treatment period.
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING THE CASES OF ULCERATED HERPETIC KERATITIS | 2001 |
|
RU2192898C1 |
REPARATIVE OPHTHALMIC MEDICINAL COMPOSITION | 2009 |
|
RU2402315C2 |
AGENT FOR TREATMENT OF TRAUMATIC INFECTIONS OF EYE ANTERIOR PART | 1996 |
|
RU2142288C1 |
METHOD FOR TREATING HERPETIC KERATOCONJUNCITIVITIS RABBITS | 1992 |
|
RU2032401C1 |
METHOD FOR DETECTING INDICATIONS FOR INTERFERONOTHERAPY IN CASE OF OPHTHALMOHERPES | 2004 |
|
RU2258224C1 |
METHOD OF TREATMENT OF CORNEA ULCERS OF PSEUDOMONAS AND GONOCOCCAL AETIOLOGY | 2006 |
|
RU2330633C1 |
METHOD FOR TREATING THE CASES OF CORNEAL DYSTROPHY | 2002 |
|
RU2220692C1 |
METHOD FOR PREVENTIVE TREATMENT AND CURING OF ULCERATIONS IN CORNEA | 1996 |
|
RU2119314C1 |
METHOD OF HERPETIC KERATITIS TREATMENT | 2007 |
|
RU2328252C1 |
ANTIHERPETIC AGENT | 1999 |
|
RU2164138C2 |
Authors
Dates
1998-12-10—Published
1996-06-17—Filed